MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.080
-0.030 (-2.70%)
Aug 5, 2026, 2:57 PM EDT - Market open
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $115.69 million as of August 5, 2026. Its market cap has decreased by -47.73% in one year.
Market Cap
115.69M
Enterprise Value
29.54M
1-Year Change
-47.73%
Ranking
Category
Stock Price
$1.08
ChartMarket Cap Chart
Since the IPO on July 30, 2021, MaxCyte's market cap has decreased from $897.06M to $115.69M, a decrease of -87.10%. That is a compound annual growth rate of -33.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 115.69M | -30.03% |
| Dec 31, 2025 | 165.34M | -62.39% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 14.96% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lucid Diagnostics | 166.28M |
| Quanterix | 163.93M |
| Quantum-Si incorporated | 155.13M |
| Owlet | 149.07M |
| Neuronetics | 137.78M |
| CVRx, Inc. | 137.32M |
| AVITA Medical | 135.45M |
| Rapid Micro Biosystems | 105.26M |